This review aims to increase awareness of the disease and to outline the strategies for its management, with a focus on patients with moderate to severe disease for whom a new therapy option is now available. Commentary is provided by Dr Brendan Cronin, a corneal and anterior segment surgeon at the Queensland Eye Institute in Brisbane.
Please login below to download this issue (PDF)